<DOC>
	<DOCNO>NCT02325232</DOCNO>
	<brief_summary>Celiac disease ( CD ) common chronic autoimmune enteropathy Western Countries estimate prevalence range 1:100 1:200 . It usually characterize benign course clinical histological remission , provide strict gluten-free diet ( GFD ) follow patient . Less frequently , CD characterize complicated course , face refractory disease ( RCD ) malignancies gastrointestinal ( GI ) tract , namely lymphoma adenocarcinoma small bowel ( SB ) . Different study estimate relative risk ( RR ) neoplastic GI complication CD range 2 40 10 60 primary gut lymphoma adenocarcinoma , respectively . Although uncommon , discussed malignancy severe prognosis , reflect need early diagnosis . This project aim establish enteroscopic approach improve diagnostic timing survival CD patient risk develop SB tumor .</brief_summary>
	<brief_title>Enteroscopy Early Diagnosis Tumors Celiac Disease</brief_title>
	<detailed_description>In last year , difficulty explore SB represent problem early diagnosis intestinal tumor . Small bowel videocapsule endoscopy ( VCE ) double-balloon enteroscopy ( DBE ) currently represent diagnostic gold standard SB mucosal lesion . The enteroscopic technique apply diagnosis management patient complicate CD , even currently available data derive retrospective investigation . Moreover , different clinical demographic risk factor SB tumor CD identify ; thus , follow statement take consideration plan diagnostic strategy SB malignancy subset CD patient : ) risk GI malignancy CD homogenously distribute ; ii ) attention pay CD patient particular demographic clinical feature ; iii ) subset CD patient early diagnostic strategy SB tumor yet evaluate . Hyphotesis Significance : In cohort CD patient particular clinical demographic characteristic possible establish programme early diagnosis small bowel complication . Specific Aim : To identify CD patient high risk develop small bowel neoplasia evaluate , subset , usefulness VCE DBE . To evaluate diagnostic yeld DBE VCE set patient . To establish flowchart early diagnosis small bowel tumor CD patient . It intention evaluate least 180-240 CD patient satisfy entry criterion , enrol three year . At least 500 OGIB control enrol include prospective retrospective ( VCE lombard registry ) part ( rate SB tumor group 0.6 % , see image preliminary data ) . The known rate SB tumor general population 0.009 % . It expect rate SB tumor select CD 5 % ( data preliminary finding ) . Comparison group ( 5 % level significance ) , neoplastic rate result expectation confirm , statistical power great 80 % . All assumption verify use SPSS ver . 18 . A P value &lt; 0.05 consider statistically significant ( significance level test 5 % , two tail ) . As mentioned , sample size calculate presume 5 % prevalence malignancy CD cohort . The normal distribution sample verify Kolmogorov-Smirnov test . Continuous variable analyze Anova Oneway variance test non parametric Kruskal-Wallis test . The significance level verify multiple comparison analysis ( Tukey Mann-Whitney ' test ) . Categorical variable compare wih X2 Fisher ' Exact test .</detailed_description>
	<mesh_term>Celiac Disease</mesh_term>
	<mesh_term>Intestinal Neoplasms</mesh_term>
	<criteria>) diagnosis celiac disease age 50 year , persistence/recurrence gastrointestinal symptom 6 month gluten free diet ii ) lack compliance gluten free diet ( define conscious regular gluten ingestion least two year ) iii ) presence alarm symptoms/signs , either diagnosis follow age low 18 year absence write informed consent participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>